SavedAdd your journal

Journals / Çocuk ve Gençlik Ruh Sağlığı Dergisi / 2014 / Cilt: 21 - Sayı: 2

FLUOXETINE TREATMENT IN PRESCHOOL CASES WITH SELECTIVE MUTISM: DISCUSSION THROUGH TWO CASES

OKUL ÖNCESİ DÖNEM SELEKTİF MUTİZM VAKALARINDA FLUOKSETİN TEDAVİSİ: İKİ OLGU EŞLİĞİNDE TARTIŞMA

İPEK PERÇİNEL
KEMAL UTKU YAZICI
Pages
123–130
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This article aims to discuss the effect of fl uoxetine on the symptoms along with the presentation of diagnostic and treatment processes of two girls with selective mutism who had applied to our unit while they were preschoolers.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Selective Mutism (SM) is identifi ed as consistent failure to speak in specifi c settings and situations in which there is an expectation for speaking though speech capacity is not impaired.
📊
Key Findings & Data:Combined interventions that would integrate medication and psychotherapeutic approaches are recommended for treatment.
💡
Conclusion & Impact:This article aims to discuss the effect of fl uoxetine on the symptoms along with the presentation of diagnostic and treatment processes of two girls with selective mutism who had applied to our unit while they were preschoolers.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Selective Mutism (SM) is identifi ed as consistent failure to speak in specifi c settings and situations in which there is an expectation for speaking though speech capacity is not impaired. Combined interventions that would integrate medication and psychotherapeutic approaches are recommended for treatment. Since it has long been believed that SM was an anxiety-based disorder and currently being categorized within anxiety disorders regarding the latest publication of DSM-5 diagnostic classifi cation, behavioral and cognitive-behavioral therapies in specifi c have been among the most frequently used treatment options for the disorder, lately. Selective serotonin reuptake inhibitors (SSRIs) are the most commonly used psychopharmacologic agents in the treatment of SM due to their anxiolytic effects. This article aims to discuss the effect of fl uoxetine on the symptoms along with the presentation of diagnostic and treatment processes of two girls with selective mutism who had applied to our unit while they were preschoolers.

Özet

Selektif Mutizm (SM), konuşabilme becerisinin olmasına rağmen konuşmanın beklendiği bir takım ortam ve durumlarda konuş(a)mama olarak tanımlanmaktadır. Tedavisinde ilaç tedavisi ve psikoterapötik girişimlerin birlikte kullanılması önerilmektedir. SM’nin geçmişten günümüze anksiyete temelli bir bozukluk olduğunun düşünülmesi ve son yayımlanan DSM-5’te anksiyete bozuklukları sınıfında yer alması nedeniyle özellikle davranışsal ve bilişsel-davranışsal terapiler son yıllarda sıklıkla kullanılan terapi seçenekleridir. Anksiyolitik etkilerinden dolayı selektif serotonin geri alım inhibitörleri (SSGI) SM tedavisinde en sık kullanılan psikofarmakolojik ajanlardır. Bu yazıda okul öncesi dönemde kliniğimize başvuran selektif mutizm tanılı iki kız olgunun tanı ve tedavi süreci ile birlikte fl uoksetinin semptomlar üzerindeki etkisinin tartışılması amaçlanmıştır.

🔖

Cite This Article

PERÇİNEL, İ., YAZICI, K. U. (2014). FLUOXETINE TREATMENT IN PRESCHOOL CASES WITH SELECTIVE MUTISM: DISCUSSION THROUGH TWO CASES. Çocuk ve Gençlik Ruh Sağlığı Dergisi, Cilt: 21 - Sayı: 2, 123–130. https://ajindex.com/articles/156948

References (13)

  1. American Psychiatric Association (APA 2000) Diagnostic and Statistical Manual of Mental Disorders (4th Ed.-Text Revision). APB Press, Washington D.C. American Psychiatric Association (APA 2013) Highlights of changes from DSM-IV-TR to DSM-5. 11 Şubat 2014’de http://www.dsm5.org/Documents/ changes%20from%20dsm-iv-tr%20to%20dsm-5.pdf adresinden indirildi. Anstendig KD (1999) Is selective mutism an anxiety disorder? Rethinking its DSM-IV classifi cation. J Anxiety Disord 13: 417-434.
  2. Berger I, Jaworowski S, Gross-Tsur V (2002) Selective mutism: a review of the concept and treatment. Isr Med Assoc J 4: 1135-1137.
  3. Black B, Uhde TW (1992) Elective mutism as a variant of social phobia. J Am Acad Child Adolesc Psychiatry 31: 1090-1094.
  4. Black B, Uhde TW (1994) Treatment of elective mutism with fl uoxetine: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 33: 1000-1006.
  5. Black B, Uhde TW (1995) Psychiatric characteristics of children with selective mutism: a pilot study. J Am Acad Child Adolesc Psychiatry 34: 847-856.
  6. Bulut S (2008) Seçici konuşmamazlık (selective mutizm): sebepleri ve tedavi yaklaşımları. Abant İzzet Baysal Üniversitesi Sosyal Bilimler Entitüsü Dergisi 17: 52-65.
  7. Carlson JS, Kratochwill TR, Johnston HF (1999) Sertraline treatment of 5 children diagnosed with selective mutism: a single-case research trial. J Child Adolesc Psychopharmacol 9: 293-306.
  8. Chavira DA, Shipon-Blum E, Hitchcock C (2007) Selective mutism and social anxiety disorder: all in the family? J Am Acad Child Adolesc Psychiatry 46: 1464-1472.
  9. Cohan SL, Chavira DA, Stein MB (2006) Practitioner review: Psychosocial interventions for children with selective mutism: a critical evaluation of the literature from 1990-2005. J Child Psychol Psychiatry 47: 1085-1097. Dummit ES 3rd, Klein RG, Tancer NK ve ark. (1996) Fluoxetine treatment of children with selective mutism: an open trial. J Am Acad Child Adolesc Psychiatry 35: 615-621.
  10. Freeman BJ, Garcia MA, Miller ML ve ark. (2004) Selective mutism. Anxiety Disorders in Children and Adolescents içinde, TL Morris, SJ March (ed) The Guilford Press, New York, s: 280-301.
  11. Göktürk Ü, Coşkun M (2008) Selektif mutizm. Çocuk ve Ergen Psikiyatrisi Temel Kitabı içinde, F Çuhadaroğlu ve ark. (ed) Hekimler Yayın Birliği, Ankara, s: 366-372.
  12. Kaakeh Y, Stumpf JL (2008) Treatment of selective mutism: focus on selective serotonin reuptake inhibitors. Pharmacotherapy 28: 214-224.
  13. Kopp S, Gillberg C (1997) Selective mutism: a population-